Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000725074 | SCV000237764 | likely benign | not provided | 2019-10-29 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000725074 | SCV000333785 | uncertain significance | not provided | 2015-08-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002362959 | SCV002659234 | likely benign | Cardiovascular phenotype | 2020-08-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV000725074 | SCV001917385 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000725074 | SCV001969052 | uncertain significance | not provided | no assertion criteria provided | clinical testing |